Lupus: Clinical Trials

1 trial for Lupus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Lupus: new trials by email Literature Review of Lupus trials Research Report on Lupus

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of ONT01 in Lupus
ONT01 is a small molecule CD11b modulator. - Lupus Nephritis (LN), Lupus Nephritis - WHO Class III
Early Phase 1RecruitingHospital for Special Surgery, New York612026-09-042025-11-20

Narrower conditions

Lupus Erythematosus, Systemic (1)  ·  Lupus Nephritis (1)

Broader conditions

Autoimmune Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Sponsors

Hospital for Special Surgery, New York (1)

Countries

United States (1)